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Abstract
The filamentous fungus Penicillium chrysogenum harbors an astonishing variety of nonribosomal peptide synthetase genes,
which encode proteins known to produce complex bioactive metabolites from simple building blocks. Here we report a
novel non-canonical tetra-modular nonribosomal peptide synthetase (NRPS) with microheterogenicity of all involved
adenylation domains towards their respective substrates. By deleting the putative gene in combination with comparative
metabolite profiling various unique cyclic and derived linear tetrapeptides were identified which were associated with this
NRPS, including fungisporin. In combination with substrate predictions for each module, we propose a mechanism for a
‘trans-acting’ adenylation domain.
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Introduction
Fungal non-ribosomal peptides contribute a large variety of
secondary metabolites with remarkable properties such as
antibacterial, antifungal, antiparasitic, anticancer and immuno-
suppressive activities. These metabolites are produced by large,
multifunctional protein complexes, called nonribosomal peptide
synthetases (NRPS). These enzymes catalyze the stepwise
condensation of simple amino acid building blocks to complex
molecules. NRPSs have a modular organization, with each
module responsible for one discrete chain-elongation step. Every
single module can be subdivided into domains that carry all
essential information for recognition, activation and modification
of the corresponding substrate. At a minimum, a typical NRPS
module consists of an adenylation (A) domain, responsible for
amino acid activation, a thiolation domain, also known as peptidyl
carrier protein (PCP), which binds the activated amino acid and a
condensation (C) domain that catalyzes peptide-bond formation.
The common arrangements of these domains follow a (C-A-PCP)n
organization. Additionally, a variety of optional domains have
been described such as methyltransferase (MT) and epimerization
(E) domains [1].
The number of modules and their domain organization within
NRPS enzymes controls the structures of the final product(s) [1–3].
Thus, the order of modules usually corresponds to the sequence of
amino acids in the peptide. Many NRPS systems adhere to this
mechanistic paradigm, which is often referred to as the ‘‘co-
linearity rule’’ [4]. Also exceptions to this rule have been
discovered, including iterative NRPSs, which incorporate multiple
residues of the same amino acid iteratively into the peptide
structure and the so called nonlinear NRPSs, which deviate
completely from the standard domain organization leading to
unexpected products [3,5,6].
The impact of non-ribosomal peptide metabolites on the quality
of human life raised the interest of pharmaceutical industries to
invest in identification, engineering and heterologous expression of
NRPS genes and pathways to ensure the rational production of
novel compounds [7–9]. To understand the basic mechanisms of
the biosynthesis of these complex NRPSs, detailed studies have
been performed during the past few decades. These included the
structural analysis of adenylation domains, mutational analysis of
substrate specificity of these modules, the fusion of unrelated
modules to produce new products and the identification of helper
proteins for optimal activation of adenylation domains [10–12].
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Although this has led to detailed insights into catalytic mecha-
nisms, so far a structure of a complete NRPS is lacking that would
reveal how modules cooperate to facilitate product formation. The
availability of genome sequencing data and sophisticated bioinfor-
matics analysis of various fungi revealed the presence of many
NRPS genes that have not been associated with known secondary
metabolites [13–15]. Moreover, most of these genes are not
expressed when the fungi are grown under laboratory conditions,
implying that many more secondary metabolites await discovery.
The filamentous fungus Penicillium chrysogenum is well known for
the production of the antibiotic penicillin G that is synthesized by
the tri-modular NRPS d-(L-a-aminoadipyl)-L-cysteinyl-D-valine
synthetase. In addition, other NRPS derived secondary metabo-
lites like the roquefortines and meleagrin have been reported from
P. chrysogenum [16–18]. Here, we describe the identification and
structural characterization of cyclic tetrapeptides (Figure 1),
including the previously identified metabolite fungisporin
[19,20], and the discovery of a tetra-modular NRPS with an
unusual domain organization with adenylation domains showing
microheterogenicity. It is proposed to term this NRPS HcpA




6-aminoquinolyl-N-hydroxysuccinimidyl carbamate (AQC) re-
agent and borate buffer were obtained as part of AccQ Tag
Reagent Kit from Waters (Waters, Milford, MA, USA). cyclo-(d-
Tyr-l-Phe-d-Val-l-Val) was obtained from Celtek Peptides (Nash-
ville, TN).
B. Host strains, media, grown condition and plasmid
construction
Deletion of the hcpA gene was carried out in P. chrysogenum strain
DS54555, which lacks penicillin cluster genes and the ku70 gene
[18]. This strain was kindly provided by the DSM Biotechnology
Center (Delft, Netherlands). A deletion plasmid was constructed by
amplifying the flanking regions of the targeted gene with the
Multisite GatewayHThree-Fragment Vector Construction Kit
according to the procedure described by Invitrogen using pDEST
R4-R3p as template. Primers used for the construction of the
deletion plasmid pDEST R4-R3p PcHcpA (Figure S1) are listed in
Table S1. Escherichia coli DH5a (F– W80lacZDM15 D(lacZYA-argF)
U169 recA1 endA1 hsdR17 (rK–, mK+) phoA supE44 l– thi-1 gyrA96
relA1) was used as host strain for high frequency transformation
and plasmid DNA amplification [21]. All the strains were grown
on yeast nitrogen base-glucose-yeast extract (YGG)-medium for
protoplasts formation and transformation [22]. Both mutant and
host strains of P. chrysogenum were grown on secondary metabolite
production medium as described previously [18].
C. Transformation procedure
The deletion plasmid pDes R4-R3p PcHcpA was transformed
to the protoplasts of P. chrysogenum DS54555 [23] yielding the
DhcpA derivative of strain DS54555 The phleomycin resistance
gene was used as selection marker for the deletion of the HcpA
gene [22,24].
D. Genomic DNA extraction, total RNA extraction, cDNA
amplification and qPCR analysis
Genomic DNA (gDNA) was isolated after 96 hours of growth
on SMP medium (secondary metabolite production medium) using
the modified yeast gDNA isolation protocol [25] in which the
fungal mycelium is broken in a FastPrep FP120 system
(Qbiogene). Isolated gDNA was measured using a NanoDrop
ND-1000. gDNA of the host and various deletion strains was
isolated using the E.Z.N.A. Fungal DNA kit (Omega Bio-tek).
Total RNA of the host strain was isolated after 48 hours of growth
in SMP medium for the first time and then with the interval of
24 hours up to 216 hours of growth using the Trizol reagent
(Invitrogen), with additional DNase treatment using the Turbo
DNA-free kit (Ambion). Total RNA was measured with the
NanoDrop ND-1000 and a concentration of 500 ng per cDNA
reaction was used. cDNA was synthesized using the iScript cDNA
synthesis kit (Bio-Rad) in a 10 ml end volume. The primers used to
analyze the expression of the hcpA gene were designed around an
intron to avoid amplification on gDNA (Table S2). For expression
analyses, the c-actin gene was used as a control for normalization
(Table S2). A negative reverse transcriptase (RT) control was used
to determine the gDNA contamination in isolated total RNA. The
expression levels were determined as described [18].
E. Southern blotting
Southern blotting was carried out by digesting gDNA (5 mg)
with the indicated restriction enzymes. Digested DNA fragments
were separated on a 0.8 % agarose gel, blotted onto a Zeta-Probe
membrane (Biorad) as described earlier [26], and hybridized with
the indicated DIG labeled probes.
Figure 1. Identified secondary metabolites. Structures of cyclic tetrapeptides identified in P. chrysogenum.
doi:10.1371/journal.pone.0098212.g001
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F. Metabolite profiling and analysis
1. Sample preparation. Host and deletion strains of P.
chrysogenum strains used for gene assignments were grown in
quintuplicate according to the procedure described above.
Samples for acquisition of the metabolite profiles from the growth
curves were from five replicates. Metabolite profiling was carried
out with modifications as described earlier [18]. Briefly, 4 ml of
internal standard mixture (855 nmol/mL ranitidine, 657 nmol/
mL reserpine and 114 nmol/mL ampicillin) was added to 100 ml
fermentation broth followed by the addition of 400 ml methanol
for protein precipitation. The samples were vortexed and spun
down at 14,000 g for 10 minutes. 300 mL supernatant was
evaporated for 30 minutes in a speedvac (Thermo Scientific, San
Jose, CA) and re-dissolved in 100 mL water. LC-UV-MS analysis
was performed on an Agilent 1200 Capillary pump (Agilent, Santa
Clara, CA) coupled in-line to a Surveyor PDA detector (Thermo
Scientific, San Jose, CA) and LTQ-FT mass spectrometer
(Thermo Scientific, San Jose, CA) using electrospray ionization
and operated in a scan range between m/z 110 and m/z 2000 in
positive/negative ion switching mode. Separation was performed
on a Waters Atlantis T3 column (2.16100 mm, 3 mm) (Waters,
Milford, MA) starting with 98 % of solvent A (1 % acetonitrile and
0.1 % formic acid in water) and 2 % solvent B (1 % water and 0.1
% formic acid in acetonitrile) for 1.5 minutes at a flow rate of
300 mL/min. 40 % B were reached after 22 minutes and 100 % B
at 25 minutes. The column was flushed with 100 % B and re-
equilibrated to initial conditions. Peak detection and integration
were performed using an in-house tool followed by statistical tests
to discover significant different features. Finally, discovered
features were integrated using LCquan v.26 (Thermo Scientific,
San Jose, CA). The non-related non-endogenous compound
reserpine was used as internal standard.
2. Identification of cyclic tetrapeptides. The identity of
cyclic tetrapeptides was determined using samples from liquid
cultures of P. chrysogenum and a crude spontaneous precipitate
obtained from P. chrysogenum cultures, containing primarily 1 and 2
next to various minor abundant cyclic tetrapeptides in relative
concentrations of 70 and 15 %, respectively. LC-MSn experiments
for the determination of consecutive amino acid losses were
performed according the metabolite profiling section with
normalized collision energies of 35 %, an isolation width of 1
amu and an activation Q of 0.30. NMR spectra were recorded on
a Bruker Avance III 700 MHz NMR spectrometer (Bruker,
Billerica, MA), equipped with a 5 mm TCI probe. 2 mg of each
sample was dissolved in 0.6 mL anhydrous DMSO. NMR spectra
were acquired at 340 K.
3. Identification of linear tetrapeptides. Linear tetrapep-
tides were identified according their multiple-stage fragmentation
after AQC derivatization [27]. Methanol (400 mL) was added to
an aliquot of 100 mL fermentation broth for protein precipitation.
Samples were vortexed for 10 minutes, spun down for 10 minutes
and 300 mL of the supernatant was evaporated to dryness in a
speedvac (Thermo Scientific, San Jose, CA). Derivatization was
done according to the supplier’s procedure by re-dissolving the
sample in 40 mL water, 40 mL borate buffer (pH 8.5) and 20 mL
AQC solution. The mixture was vortexed for 10 minutes and
heated for 10 minutes at 55uC.
LC-MSn experiments were conducted on an Agilent 1200
Capillary pump (Agilent, Santa Clara, CA) coupled to a LTQ-FT
mass spectrometer (Thermo Scientific, San Jose, CA) using
electrospray ionization. Separation was performed on a Waters
Atlantis T3 column (2.16100 mm, 3 mm) (Waters, Milford, MA)
starting with 72 % of solvent A (1 % acetonitrile and 0.1 % formic
acid in water) and 28 % of solvent B (1 % water and 0.1 % formic
acid in acetonitrile) for 1.5 minutes at a flow rate of 300 mL/min.
After 8 minutes the gradient reached 60 % of solvent B.
Subsequently, the column was flushed with 100 % B before it
was re-equilibrated to initial conditions. The peptide sequences
were elucidated using multiple-stage collision-induced dissociation
(CID) of the protonated molecule following consecutive cleavages
of amino acids residues, starting from the C-terminus of the
derivatized linear tetrapeptide. CID was performed with normal-
ized collision energies of 35 %, an isolation width of 1 amu and an
activation Q of 0.30.
Results
Bioinformatic analysis of a tetrapeptide NRPS
Genome sequencing revealed that P. chrysogenum encodes 11
NRPS genes [15]. Microarray expression analysis under glucose-
limited chemostat culture conditions as well as quantitative PCR
under shake flask culture condition showed that Pc16g04690
(genbank protein identifier CAP93139.1) (hcpA) is highly expressed
(Figure 2A) [15]. The hcpA gene encodes a large multimodular
non-ribosomal peptide synthetase enzyme (Figure 3) with 6064
amino acids and a calculated molecular mass of about 670 kDa.
HcpA, which shows 54% sequence identity to the orthologous
An08g02310 in A. niger, has the domain architecture A1-PCP1-E-
C2-A4-A2-PCP2-C3-A3-PCP3-E-C4-PCP4-C-PCP (A= adenyla-
tion, C= condensation, PCP= thiolation, and E= epimerization)
(Figure 3A) [15]. A similar domain architecture was deduced for
the orthologous protein of A. niger except for an insertion of a 177
amino acid long sequence between the adenylation domain A4 and
A2 which shows homology to conserved motifs of an incomplete
condensation domain (Co) (Figure 3A). To predict the substrate
specificity of the four adenylation domains of the two HcpA
proteins, NRPSPredictor2 was used [28]. This program extracted
the active site amino acid motifs DAACVAGVAK and DA-
VIIAAVAK as the signature sequences for the A1 domain in the P.
chrysogenum and A. nidulans HcpA proteins. This motif exhibits
similarity with the signature sequence of the adenylation domain
of a bacitracine-producing NRPS that activates phenylalanine as a
substrate. The signature sequences for the A4 domain (DAVSAG-
VAAK and DMQSAWFICK in the P. chrysogenum and A. nidulans
HcpA, respectively) shows homology with the valine-activating
adenylation domain of the gramicidin synthetase, whereas the A2
(DAMTVGGVFK and DVLSTGAICK for the P. chrysogenum and
A. nidulans HcpA, respectively) and A3 (DAMFVGGVFK and
DAMFVGGIFK for the P. chrysogenum and A. nidulans HcpA,
respectively) domains have predicted specificities towards phenyl-
alanine and valine, respectively. The overall architecture of both
synthetases is unusual, as the A2 and A4 domains occur adjacent to
each other, flanked by a single C and PCP domain in a C2-A4-A2-
PCP2 pattern. On the other hand, an incomplete module (C4-
PCP4) without an adjacent A domain is found at the N-termini of
these NRPSs (Figure 3A).
Genetic deletion of the tetrapeptide NRPS and secondary
metabolite identification
In order to identify the secondary metabolites synthetized by
HcpA, the corresponding gene was deleted and comparative
metabolite profiling was performed on the culture supernatant of
the host and deletion strain. As host strain, P. chrysogenum DS54555
was used, which is derived from the industrial DS17690 strain and
that lacks the ku70 gene to make it competent for homologous
recombination. The DS54555 strain also lacks the multiple
penicillin biosynthetic genes clusters in order to facilitate the
detection of unknown secondary metabolites in the culture broth
Hydrophobic Cyclic Tetrapeptide Biosynthesis
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as the profile is no longer dominated by b-lactams. The hcpA gene
was resequenced from the genome of P. chrysogenum DS54555 and
the nucleotide sequence of the open reading frame (genbank
KJ679502) including the promotor region was found to be
identical to the hcpA gene present in the sequenced genome of P.
chrysogenum Wisconsin54-1255 [15]. The gene deleted by homol-
ogous recombination using the deletion plasmid pDEST R4-R3p
(Figure S1) containing the flanking regions of hcpA and the
phleomycin resistance gene. Colonies were selected on phleomycin
containing agar plates where the mutant colonies showed smooth
phenotypic characteristics compared to the wrinkled surface of the
colonies of the parental strain (Figure 4). The deletion of the hcpA
gene was confirmed by southern blot hybridization (Figure 5A).
The host and DhcpA strain were grown for 168 hours in SMP
Medium followed by comparative metabolite analysis using
HPLC-UV-MS. Several secondary metabolites were found to be
present in the host but absent in the deletion strain (Figure 6,
Table S3). These compounds could be classified into two groups
according their chemical structure. The first group consists of ten
cyclic tetrapeptides, which were identified using HPLC-MSn,
NMR and a synthetic standard (Figure 1). Upon excitation, cyclic
tetrapeptides undergo ring opening in the mass spectrometer
resulting in four linear tetrapeptides, which can be sequenced in a
similar fashion as linear peptides. By following the sequential loss
of amino acids from b-ions of each generated linear tetrapeptide,
the sequence of their cyclic origin could be determined (Figure S2).
The identities of the involved amino acids, corresponding to the
losses in the mass spectrometer, as well as their sequence were
additionally confirmed by 1H-NMR and 13C-NMR experiments
for the compounds 1 and 2 (Table S4 and S5). To discriminate the
amino acid isoleucine from its isomer leucine, which is represented
by a loss of 113 Da (C6H11ON) in the mass spectra of compounds
5–10, 1H-, 13C- and various 2D-NMR experiments were
conducted (Figure S3, Table S6). Overall, cyclic tetrapeptides
obtained from metabolic profiling contain various combinations of
the five amino acids valine, isoleucine, phenylalanine, tyrosine and
tryptophan making them extremely hydrophobic. They are
arranged in a common sequence in which two aromatic amino
acids are followed by two aliphatic amino acids. The absolute
stereochemistry of compound 2 was confirmed by spiking its
synthetic standard to a natural extract, which did not lead to
additional signals in the 1H-NMR spectra, whereas the intensity of
the main signals increased as compared to the impurities (Figure
S4A and B). In addition, superimposing the HMBC spectra of the
natural and the synthetic sample of peptide 2 illustrated identical
correlations and shifts (Figure S5). Furthermore, retention time
and MS2 fragmentation did not show differences between the
extracted compound and the synthesized standard. This leads to
the conclusion that not only the sequence of amino acids is
identical in the synthetic and natural peptide, but also the chirality
Figure 2. Correlation between the expression level of HcpA and metabolite formation during growth. A: Time dependent expression
level of hcpA as determined by quantitative RT-PCR during growth of P. chrysogenum as monitored by biomass formation. B: Internal standard
corrected concentration of the cyclic peptide 1 and its degradation products 11–13 present in the growth media. The concentration of peptides was
determined by HPLC-UV-MS.
doi:10.1371/journal.pone.0098212.g002
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Figure 3. Hypothetical model for the biosynthesis of compound 1 in P. chrysogenum and A. niger by the HcpA NRPS. A: Binding of the
monomers on the carrier protein domains. Both isolated condensation and thiolation domains C4 and T4, missing a preceding adenylation domain,
are assumed to correspond to the adenylation domain A4, located upstream. B: Proposed assembly of compound 1 including condensation domains
presumed for catalyzing the formation of the peptide bond.
doi:10.1371/journal.pone.0098212.g003
Hydrophobic Cyclic Tetrapeptide Biosynthesis
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of the individual amino acids. Therefore, the cyclic tetrapeptide 2
has the same stereochemistry as observed for 1 [19] with the first
amino acid of an aliphatic and aromatic pair in D- and the second
amino acid in L-form. Due to the low concentration of cyclic
tetrapeptides 3–10, reliable stereochemical information could not
be obtained. However, as these peptides originate from the same
NRPS as 1–2 and share the same sequence of aliphatic and
aromatic amino acids, identical stereochemistry is expected.
The second category of identified compounds consists of 18
linear tetrapeptides which are comprised of the same five amino
acids as their cyclic analogues (Table S3 and S7). Similar to the
cyclic peptides, each linear tetrapeptide contains two aliphatic and
two aromatic amino acids in different arrangements yielding
various isomeric structures. Due to similar chromatographic
properties and an identical mass-over-charge ratio, these isomers
are represented as a group in data obtained from metabolic
profiling (Figure S6A and B). Their structure elucidation is
challenging as minor fragments can be attributed to a fragmen-
tation of low abundant linear tetrapeptides as well as to possible
sequence scrambling of major linear tetrapeptides which was
reported for similar linear peptides [29]. To separate and sequence
these isomeric tetrapeptides and to prevent possible sequence
scrambling, their N-terminus was derivatized using 6-aminoqui-
nolyl-N-hydroxysuccinimidyl carbamate (AQC) (Figure S6C and
D) [30]. De novo peptide sequencing was performed by following
the consecutive amino acid losses of various b-ions using multiple-
stage fragmentation mass spectrometry (Figure S6E and Table S7).
Similar to the cyclic peptides, each linear tetrapeptide incorporates
two consecutive aromatic and/or two consecutive aliphatic amino
acids.
In conclusion, several linear and cyclic tetrapeptides with similar
structural features were found to be present in the host but absent
in the deletion strain which shows that they originate from one
single NRPS, namely HcpA.
Expression of the hcpA gene and secondary metabolite
production
To examine the expression of the hcpA gene, the host strain was
grown for up to 216 hours in SMP medium. Samples were
collected for total mRNA extraction and extracellular metabolites
analysis during growth. Metabolite concentrations were deter-
mined by HPLC-UV-MS, while transcript levels were determined
by quantitative PCR using c-actin as a reference gene. A high
expression level of the hcpA gene was observed between 120 and
168 hours of growth, which was paralleled by a 12 times increase
in the concentration of cyclic tetrapeptide 1 (Figure 2A and B) in
the medium. In general, the concentration of cyclic tetrapeptides
was exceptionally high around 168 hours of growth, while the
concentration of the linear tetrapeptides increased with time.
These data suggest that the linear tetrapeptides are derived from
the cyclic tetrapeptides by degradation.
Discussion
Here we have demonstrated that the NRPS HcpA is responsible
for the biosynthesis of cyclic hydrophobic tetrapeptides. Bioinfor-
matics analysis of HcpA shows an unusual domain architecture in
comparison to classical linear NRPSs with no products associated
so far. However, through the deletion of the hcpA gene and
comparative metabolite profiling, ten cyclic tetrapeptides were
identified, including the previously described secondary metabolite
fungisporin 1 [19]. According to the non-ribosomal code in
combination with discovered cyclic products, the first NRPS
module is specific for phenylalanine. Due to the adjacent E
domain, responsible for epimerization of the activated amino acid,
Figure 4. Colonies of P. chrysogenum strain DS54555. A: Colony
of the wild type strain showing a wrinkled surface. B: Colony of the
DhcpA strain with a smooth surface.
doi:10.1371/journal.pone.0098212.g004
Figure 5. Southern blot analysis for the hcpA deletion and
concentration of cyclic tetrapeptides in culture broth of host
strain. A: Southern blot hybridization validating the complete gene
deletion of hcpA. B: Internal standard corrected concentrations of the
cyclic tetrapeptides 1–10 present in the culture broth of the host strain
of P. chrysogenum grown for 168 hours. Isomers are presented together
as no chromatographic separation was obtained during profiling. No
cyclic or linear tetrapeptides could be found in the deletion strain.
doi:10.1371/journal.pone.0098212.g005
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a D-configuration is expected as observed for product 1 (Figure 1).
The next two modules of the NRPS contain an unusual
architecture in which PCP2 and C3 are flanked by two
neighboring adenylation domains A2 and A4. As adenylation
domain A4 shows high specificity towards valine and adenylation
domain A2 shows high homology towards A1, both adenylation
domains activate phenylalanine as supported by the structure of 1.
Due to the lack of an adjacent PCP domain for A4 and a missing C
domain for A2, which are necessary for loading and condensation
of the substrate, no module activity is expected according to the
classical C-A-PCP geometry (Figure 3A). Surprisingly, both
products 1 and 2 show the incorporation of L-phenylalanine at
the second position. As module 2 is predicted to be the only
module capable to catalyze the incorporation of L-phenylalanine,
A2 indeed must be active. Consequently, it seems likely that A4 is
skipped, leaving the N-terminal C2 domain of module 2 to catalyze
the condensation of the first amino acid from module 1 to the
second amino acid from module 2, as observed for the products 1
and 2. The third module of HcpA contains the domains C3, A3,
PCP3 and E arranged in a common linear order. The A3 domain
is predicted to activate valine, which agrees with the peptide
sequence of 1 and 2, as D-valine is their third amino acid. The
fourth module of the NRPS is an incomplete module consisting of
C4 and PCP4. Due to a missing preceding A domain no activity is
expected. However, the chemical structures of both cyclic
tetrapeptides 1 and 2 show the incorporation of L-valine as fourth
amino acid in their peptide sequence. As A4 is the only domain
predicted to be specific to valine without an adjacent epimeriza-
tion domain, it is very likely that this domain is a ‘trans-acting’ A
domain that interacts with C4 and PCP4 to add the last amino acid
to the tetrapeptide. A similar architectural flexibility has been
observed in the biosynthesis of yersiniabactin, in which one A
domain, located in HMWP2, loads three PCPs located on
different modules [31–33]. As the linear domain organization of
HcpA does not reflect a linear assembly of substrate incorporation
into the final product, non-linear interactions are deduced.
Although A4, C4 and PCP4 are not in a consecutive sequence
on a genomic level, they might still be closely arranged in the final
three-dimensional enzymatic structure. Structural characterization
would be necessary to determine spatial proximity. Finally, after
the incorporation of L-valine into the peptide chain, the C and
PCP domain of the last module catalyze the cyclization of the
peptide leading to the final cyclic structure, as previously observed
in other NRPS systems [34,35]. It should be stressed that non-
linear NRPS organizations are a very heterogenous group of
NRPS systems which deviate from the colinearity rule thus
showing various unusual mechanisms [6]. In an alternative model
A4 might be non-functional, leaving A3 loading two PCPs, namely
PCP3 and PCP4, similar to the cysteine-specific A domain of
HMWP2 in yersiniabactin biosynthesis [3]. However, more
detailed biochemical studies are required to fully understand the
interplay between these enzymes and to confirm the exact
biosynthetic mechanisms involved.
Next to the production of 1 and 2, eight additional lower
abundant cyclic tetrapeptides were identified to be present in the
host strain and absent in the deletion strain (Figure 1). They show
a similar peptide sequence as 1, containing two aromatic amino
acids followed by two aliphatic amino acids. Although stereo-
chemical information is only available for the compounds 1 and 2,
it can be assumed that each of the cyclic tetrapeptides contains an
aliphatic and aromatic amino acid in the D configuration, more
specifically at the first and third position. These assumptions in
combination with the stereochemical structure of 1 and 2 lead to
the conclusion, that each adenylation domain of HcpA shows
specificity towards more than one precursor amino acid with A1
being specific towards phenylalanine and tyrosine and A2 being
specific towards phenylalanine and to a lesser extent to tryptophan
(Table S8) reminiscent of microheterogenicity. Together with the
two aliphatic amino acid selecting adenylation domains A3 and A4,
which preferably activate valine before isoleucine, 16 cyclic
tetrapeptide combinations are theoretically possible. However,
only ten of these were detected in the fermentation broth of P.
chrysogenum confirming a different degree of specificity towards
their precursors. Based on a similar chemical scaffold of identified
Figure 6. HPLC-MS elution profiles of the internal standard reserpine and the highest abundant identified peptides. Total ion
chromatogram (TIC, black) and normalized extracted ion chromatograms (EIC, colored) of the protonated molecule ([M+H]+ with 5 ppm accuracy) of
the used internal standard reserpine (A), the four highest abundant cyclic tetrapeptides 1 (B), 2 (C), 3 (D), 4 (E) and linear tetrapeptides 11–13 (F), 14–
16 (G), 17–19 (H), 20–22 (I) present in the culture broth of P. chrysogenum.
doi:10.1371/journal.pone.0098212.g006
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compounds 1–10 to the tetrapeptides cyclo-(N-MePhe-Ile)2, cyclo-
(N-MePhe-Val)2 and cyclo-(N-MePhe-Val-N-MePhe-Ile) reported
from Onychocola sclerotic, cardiac channel blocking activities can be
expected for the hydrophobic cyclic peptides presented here [36].
In addition, the colonies of the DhcpA strain lost the ability to
produce a wrinkled surface leading to a rather smooth appearance
(Figure 4). As this change is attributed to the deletion of the hcpA
gene, the hydrophobic cyclic peptides 1–10 need to be involved.
Possibly, these molecules function analogous to hydrophobins in
altering the surface properties and influencing aerial growth. The
exact function is, however, still unclear.
In addition to the cyclic tetrapeptides several highly abundant
linear tetrapeptides could be observed in the cultural broth of the
host strain that were absent in the deletion strain. To each of the
cyclic tetrapeptides, several linear tetrapeptides with the same
sequence were present. For instance, for the cyclic tetrapeptide 1
with the sequence cyclo-(Phe-Phe-Val-Val), three linear tetrapep-
tides with the sequences Phe-Val-Val-Phe, Val-Phe-Phe-Val and
Phe-Phe-Val-Val could be found at different ratios. Their
concentration increased over time in the media while their cyclic
counterpart decreased after 168 hours (Figure 2B). This leads to
the conclusion that the linear peptides originate from the
degradation of their cyclic counterparts by hydrolysis of their
peptide bonds, which was observed exclusively between two
aromatic, two aliphatic or an aliphatic followed by an aromatic
amino acid (Table S3 and S7). Linear tetrapeptides with a N-
terminal aliphatic amino acid and a C-terminal aromatic amino
acid were not detected, leading to the conclusion that cleavage of
this bond is not favorable. As cyclic tetrapeptides are relatively
stable towards chemical and thermal degradation, enzymatic
hydrolysis might be most probable.
P. chrysogenum contains a second NRPS that could potentially be
involved in tetrapeptide formation, i.e., Pc13g14330. This protein
has a linear organization and thus differs from the HcpA protein.
Pc13g14330 is hardly expressed under batch culture conditions as
employed in this study. Moreover, overexpression of Pc13g14330
under control of the strong pcbC promoter did not lead to any
novel detectable metabolite in the growth medium, nor did the
deletion of the Pc13g14330 gene affect the cyclic tetrapeptide
production or result in a loss of other metabolites (unpublished
data). Therefore, we conclude that Pc13g14330 is unrelated to
HcpA, and not responsible for cyclic tetrapeptide formation.
HcpA shows 54% amino acid sequence identity with the
orthologous protein from A. niger with exactly the same module
organization (Figure 3A). Furthermore, all cyclic products 1–10
present in P. chrysogenum could also be found in the supernatant of
an A. niger strain while they were absent in the HcpA deletion strain
(unpublished data). Therefore, it is concluded that HcpA is
involved in production of all cyclic metabolites (1–10) in A. niger. A
small difference exists in the organization of both HcpA proteins
with a short additional amino acid sequence present between
domains A4 and A2 in the A. nidulans enzyme. This sequence
showed limited homology to a condensation domain and appears
as an incomplete condensation domain. Hence, one may deduce
that this non-canonical situation might have evolved quite
recently. Perhaps, a complete C-A-PCP-C-A-PCP module struc-
ture was present before, but degenerated after new interactions
between the domains evolved.
Conclusions
Cyclic tetrapeptides are a structurally interesting group of
peptides produced by fungi that have attracted much interest
because of their cardiac ion-channel blocking properties. The
complete biosynthetic mechanism of these metabolites has been
deduced by gene deletion experiments in P. chrysogenum in
combination with comparative metabolite profiling and consecu-
tive structure elucidation. By this analysis, trans-aminoacylation for
chain elongation in NRPS has been found. Furthermore, a distinct
microheterogenicity of each adenylation domain towards different
amino acid building blocks resulted in a range of cyclic
tetrapeptides as produced by a single NRP synthetase.
Supporting Information
Figure S1 Plasmid used for the deletion of the hcpA
gene in P. chrysogenum.
(TIF)
Figure S2 Multiple-stage fragmentation for de novo
sequencing of compound 2 based on sequential amino
acid losses. A: MS2 fragmentation spectra of the cyclic
tetrapeptide 2 cyclo-(d-Tyr-l-Phe-d-Val-l-Val). Due to ring opening
of the cyclic peptide in the mass spectrometer at different positions,
three different amino acid losses occurred, yielding different b3-
ions. B-D: MS3 fragmentation spectra obtained by further
fragmenting b3-ions from MS
2 showing b2-ions used for peptide
sequencing. The cyclic tetrapeptides 1 and 3–10 were identified
accordingly.
(TIF)
Figure S3 HSQC spectrum of isolated mixture of cyclic
tetrapeptides in DMSO. The spectra were used for the
identification of isoleucine present in the minor abundant products
5 and 9. Signals corresponding to isoleucine are indicated with
circles. Conducted TOCSY, COSY and HMBC experiments
further confirm this conclusion (data not shown). 1H and 13C
chemical shifts are shown in Table S6.
(TIF)
Figure S4 1H-NMR spectra of mixtures of cyclic tetra-
peptides. A: 1H-NMR spectrum of a precipitate of various cyclic
tetrapeptides containing primarily peptide 1 and 2 (bottom).
Synthetic compound 2 spiked to the precipitated mix of various
cyclic tetrapeptides in DMSO at 340 K (top). Signals correspond-
ing to 2 were increased as compared to the impurities whereas
additional signals did not appear. B: Zoomed regions of 1H-NMR
spectrum of natural precipitate (bottom) and precipitate spiked
with compound 2 (top). Signals which increased after spiking are
indicated (*).
(TIF)
Figure S5 Superimposed HMBC spectra of synthetic
compound 2 (red) and an isolated mixture of cyclic
tetrapeptides containing naturally produced compound
2 (black). Correlations between NH and CO are shown which
indicate identical shifts for both samples. Assignments can be
found in Table S4.
(TIF)
Figure S6 Sequencing of the linear isomers 11 (Phe-Phe-
Val-Val), 12 (Val-Phe-Phe-Val) and 13 (Phe-Val-Val-Phe).
A: Extracted ion chromatogram (EIC) of the linear tetrapeptides
11, 12 and 13 using the profiling method. No chromatographic
separation could be achieved. B: MS2 fragmentation spectrum of
unseparated linear tetrapeptides 11–13. Although the spectrum is
dominated by fragments originating from 11, several lower
abundant fragments can be found originating from a fragmenta-
tion of 12 and 13 or possible sequence scrambling of 11. C:
Sequence of linear tetrapeptides after N-terminal AQC derivati-
zation to achieve better chromatographic separation and to
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prevent sequence scrambling. D: Normalized total ion chromato-
gram (TIC) of AQC derivatized linear peptides 11–13 after first C-
terminal amino acid loss showing chromatographic separation and
allowing peptide sequencing. E: Individual MS3 fragmentation
spectra of chromatographically separated derivatized peptides 11,
12 and 13 showing b2 and b1 ions used for peptide sequencing.
The linear peptides 14–28 were identified accordingly.
(TIF)
Table S1 Primers designed for making the hcpA
deletion construct in P. chrysogenum.
(DOCX)
Table S2 Primers designed for the expression analysis
of the hcpA and actin gene.
(DOCX)
Table S3 Retention time, formula and acquired m/z of
cyclic and linear tetrapeptides obtained from metabolic
profiling. Isomers have the same retention time as they could not
be chromatographically separated during profiling.
(DOCX)
Table S4 1H and 13C-NMR chemical shifts of syntheti-
cally produced compound 2 with sequence cyclo-(d-Tyr-
l-Phe-d-Val-l-Val) in DMSO at 340 K. As synthetically and
naturally produced 2 show identical NMR spectra, only chemical
shifts for the synthetically produced compound are shown. dDMSO
(1H/13C) = (2.55/40.50), (d in ppm).
(DOCX)
Table S5 1H and 13C chemical shifts of naturally
produced compound 1 with sequence cyclo-(d-Phe-l-
Phe-d-Val-l-Val) present in a mix of various cyclic
tetrapeptides in DMSO acquired at 340 K. Signals
overlapping with the highest abundant compound 2 are indicated
(*). dDMSO (
1H/13C) = (2.55/40.50), (d in ppm).
(DOCX)
Table S6 1H and 13C chemical shifts of isoleucine in
compound 5 with sequence cyclo-(Phe-Phe-Val-Ile) and
compound 9 with sequence cyclo-(Phe-Phe-Val-Ile) pres-
ent in a extracted mix of cyclic tetrapeptides. NMR signals
corresponding to C=O and NH as well as remaining amino acid




Table S7 Sequencing data leading to the identification
of linear tetrapeptides after AQC derivatization. Multi-
ple-stage fragmentation was used for determination of b-ions for
de-novo peptide sequencing.
(DOCX)
Table S8 Identified and proposed cyclic and linear
tetrapeptides in respect to the adenylation domain
specificity in the NRPS HcpA.
(DOCX)
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Supplementary Figure 1. 
Plasmid used for the deletion of the hcpA gene in P. chrysogenum 
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Supplementary Figure 2. Multiple-stage fragmentation for de novo sequencing of 
compound 2 based on sequential amino acid losses 
A: MS2 fragmentation spectra of the cyclic tetrapeptide 2 cyclo-(d-Tyr-l-Phe-d-Val-l-Val). Due to 
ring opening of the cyclic peptide in the mass spectrometer at different positions, three different 
amino acid losses occurred, yielding different b3-ions.  
B-D: MS3 fragmentation spectra obtained by further fragmenting b3-ions from MS2 showing b2-
ions used for peptide sequencing.  
 
The cyclic tetrapeptides 1 and 3-10 were identified accordingly. 
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Supplementary Figure 3.  
HSQC spectrum of isolated mixture of cyclic tetrapeptides in DMSO used for the identification of 
isoleucine present in the minor abundant products 5 and 9. Signals corresponding to isoleucine 
are indicated with circles. Conducted TOCSY, COSY and HMBC experiments further confirm 
this conclusion (data not shown). 1H and 13C chemical shifts are shown in Supplementary Table 
6. 
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Supplementary Figure 4. 
A: 1H-NMR spectrum of a precipitate of various cyclic tetrapeptides containing primarily peptide 
1 and 2 (bottom). Synthetic compound 2 spiked to the precipitated mix of various cyclic 
tetrapeptides in DMSO at 340 K (top). Signals corresponding to 2 were increased as compared 
to the impurities whereas additional signals did not appear. 
B: Zoomed regions of 1H-NMR spectrum of natural precipitate (bottom) and precipitate spiked 
with compound 2 (top). Signals which increased after spiking are indicated (*). 
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Supplementary Figure 5.  
Superimposed HMBC spectra of synthetic compound 2 (red) and an isolated mixture of cyclic 
tetrapeptides containing naturally produced compound 2 (black). Correlations between NH and 
CO are shown which indicate identical shifts for both samples. Assignments can be found in 
Supplementary Table 4. 
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Supplementary Figure 6. Sequencing of the linear isomers 11 (Phe-Phe-Val-Val), 12 (Val-
Phe-Phe-Val) and 13 (Phe-Val-Val-Phe).  
A: Extracted ion chromatogram (EIC) of the linear tetrapeptides 11, 12 and 13 using the 
profiling method. No chromatographic separation could be achieved. 
B: MS2 fragmentation spectrum of unseparated linear tetrapeptides 11-13. Although the 
spectrum is dominated by fragments originating from 11, several lower abundant fragments can 
be found originating from a fragmentation of 12 and 13 or possible sequence scrambling of 11.  
C: Sequence of linear tetrapeptides after N-terminal AQC derivatization to achieve better 
chromatographic separation and to prevent sequence scrambling. 
D: Normalized total ion chromatogram (TIC) of AQC derivatized linear peptides 11-13 after first 
C-terminal amino acid loss showing chromatographic separation and allowing peptide 
sequencing. 
E: Individual MS3 fragmentation spectra of chromatographically separated derivatized peptides 
11, 12 and 13 showing b2 and b1 ions used for peptide sequencing. 
 
The linear peptides 14 – 28 were identified accordingly 










Supplementary Table 1. 
Primers designed for making the hcpA deletion construct in P. chrysogenum. 
 
 
Target Primer sequence (5’- 3’) 








Supplementary Table 2. 























1 cyclo-(FFVV) 27.33 C28H36N4O4 493.2806 -0.673 
2 cyclo-(YFVV) 26.63 C28H36N4O5 509.2757 -0.288 
3 cyclo-(YWVV) 26.59 C30H37N5O5 548.2868 0.099 
4 cyclo-(FWVV) 27.21 C30H37N5O4 532.2916 -0.434 
5 cyclo-(FFVI) 27.56 C29H38N4O4 507.2962 -0.753 
6 cyclo-(FFIV) 27.56 C29H38N4O4 507.2962 -0.753 
7 cyclo-(YWVI) 26.86 C31H39N5O5 562.3017 -1.237 
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8 cyclo-(YWIV) 26.86 C31H39N5O5 562.3017 -1.237 
9 cyclo-(YFVI) 26.90 C29H38N4O5 523.2914 -0.185 
10 cyclo-(YFIV) 26.90 C29H38N4O5 523.2914 -0.185 
11 FVVF 23.34 C28H38N4O5 511.2912 -0.580 
12 VFFV 23.34 C28H38N4O5 511.2912 -0.580 
13 FFVV 23.34 C28H38N4O5 511.2912 -0.580 
14 YFVV 20.06 C28H38N4O6 527.2864 -0.022 
15 VYFV 20.06 C28H38N4O6 527.2864 -0.022 
16 FVVY 20.06 C28H38N4O6 527.2864 -0.022 
17 YWVV 20.40 C30H39N5O6 566.2972 -0.195 
18 VYWV 20.40 C30H39N5O6 566.2972 -0.195 
19 WVVY 20.40 C30H39N5O6 566.2972 -0.195 
20 VFWV 23.57 C30H39N5O5 550.3023 -0.174 
21 FWVV 23.57 C30H39N5O5 550.3023 -0.174 
22 WVVF 23.57 C30H39N5O5 550.3023 -0.174 
23 FVIF 24.66 C29H40N4O5 525.3077 1.053 
24 FIVF 24.66 C29H40N4O5 525.3077 1.053 
25 FVIY 21.43 C29H40O6N4 541.3023 0.441 
26 IYFV 21.43 C29H40O6N4 541.3023 0.441 
27 FIVY 21.43 C29H40O6N4 541.3023 0.441 
28 VYFI 21.43 C29H40O6N4 541.3023 0.441 
 
Supplementary Table 3. 
Retention time, formula and acquired m/z of cyclic and linear tetrapeptides obtained from 
metabolic profiling. Isomers have the same retention time as they could not be 
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amino acid position δ (1H)  Position δ(13C)  
 
d-Tyr 
α 4.53  α 54.10  
β1 2.93  β 34.59  
β2 2.69  γ 128.43  
δ 6.99  δ 130.32  
ε 6.65  ε 115.63  
NH 7.82  ζ 156.35  
OH 8.99  C=O 173.35  
l-Phe 
α 4.62  α 53.97  
β1 3.05  β 35.47  
β2 2.80  γ 138.48  
δ 7.20  δ 129.41  
ε 7.21  ε 128.68  
ζ 7.26  ζ 126.72  
NH 7.80  C=O 173.56  
d-Val 
α 4.00  α 59.90  
β 2.00  β 27.66  
γ1 0.87  γ1 19.76  
γ2 0.82  γ2 19.01  
NH 7.58  C=O 173.81  
l-Val 
α 3.98  α 59.71  
β 2.00  β 27.51  
γ1 0.90  γ1 19.73  
γ2 0.80  γ2 19.07  
NH 7.62  C=O 173.32  
 
Supplementary Table 4. 
1H and 13C-NMR chemical shifts of synthetically produced compound 2 with sequence cyclo-(d-
Tyr-l-Phe-d-Val-l-Val) in DMSO at 340 K. As synthetically and naturally produced 2 show 
identical NMR spectra, only chemical shifts for the synthetically produced compound are shown. 
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amino acid position δ (1H)  Position δ(13C)  
 
d-Phe 
α 4.62*  α 53.69  
β1 3.05*  β 35.29  
β2 2.80*  γ 138.40  
δ 7.20*  δ 129.43  
ε 7.21*  ε 128.66  
ζ 7.26*  ζ 126.74  
NH 7.88  C=O 173.16  
l-Phe 
Α 4.62*  α 54.03  
β1 3.05*  β 35.56  
β2 2.80*  γ 138.44  
δ 7.20*  δ 129.42  
ε 7.21*  ε 128.68*  
ζ 7.26*  ζ 126.72*  
NH 7.78  C=O 173.56*  
d-Val 
α 4.00*  α 59.88  
β 2.00*  β 27.61  
γ1 0.86  γ1 19.77  
γ2 0.81  γ2 19.01*  
NH 7.58  C=O 173.79  
 
l-Val 
α 3.98*  α 59.73  
β 2.00*  β 27.54  
γ1 0.89  γ1 19.67  
γ2 0.78  γ2 19.06  
NH 7.58  C=O 173.36  
 
 
Supplementary Table 5. 
1H and 13C chemical shifts of naturally produced compound 1 with sequence cyclo-(d-Phe-l-Phe-
d-Val-l-Val) present in a mix of various cyclic tetrapeptides in DMSO acquired at 340 K. Signals 
overlapping with the highest abundant compound 2 are indicated (*). δDMSO (1H/13C) = 














amino acid position δ (1H)  Position δ(13C)  
Ile in 5 
α 4.1  α 57.8  
β 1.85  β 34.0  
γ1 0.76  γ1 15.0  
γ2 1.3  γ2 26.5  γ2´ 1.1   
δ 0.9  δ 11.0  
NH n.o.  C=O n.o.  
 
Ile in 9 
α 4.1  α 57.5  
β 1.85  β 33.5  
γ1 0.74  γ1 16.0  
γ2 1.5  γ2 24.5  γ2´ 1.15   
δ 0.85  δ 10.5  
NH n.o.  C=O n.o.  
	  
Supplementary Table 6. 
1H and 13C chemical shifts of isoleucine in compound 5 with sequence cyclo-(Phe-Phe-Val-Ile) 
and compound 9 with sequence cyclo-(Phe-Phe-Val-Ile) present in a extracted mix of cyclic 
tetrapeptides. NMR signals corresponding to C=O and NH as well as remaining amino acid 































b3 ion in 
MS2 
 
b2 ion in MS3 
derived from 
b3 ion 





min   m/z m/z (loss) m/z (loss) m/z (loss) 
11 FVVF 7.50 C38H44N6O6 681 516 (-F) 417 (-V) 318 (-VV) 
12 VFFV 7.71 C38H44N6O6 681 564 (-V) 417 (-F) 270 (-FF) 
13 FFVV 7.98 C38H44N6O6 681 564 (-V) 465 (-V) 318 (-FV) 
14 YFVV 4.46 C38H44N6O7 697 580 (-V) 481 (-V) 334 (-FV) 
15 VYFV 3.28 C38H44N6O7 697 580 (-V) 433 (-F) 270 (-YF) 
16 FVVY 3.85 C38H44N6O7 697 516 (-Y) 417 (-V) 318 (-VV) 
17 YWVV 4.20 C40H45N7O7 736 619 (-V) 520 (-V) 334 (-WV) 
18 VYWV 2.55 C40H45N7O7 736 619 (-V) 433 (-W) 270 (-YW) 
19 WVVY 3.64 C40H45N7O7 736 555 (-Y) 456 (-V) 357 (-VV) 
20 VFWV 7.01 C40H45N7O6 720 603 (-V) 417 (-W) 270 (-FW) 
21 FWVV 7.78 C40H45N7O6 720 603 (-V) 504 (-V) 318 (-WV) 
22 WVVF 7.41 C40H45N7O6 720 555 (-F) 546 (-V) 357 (-VV) 
23 FVIF 8.24 C39H46N6O6 695 530 (-F) 417 (-I) 318 (-VI) 
24 FIVF 8.38 C39H46N6O6 695 530 (-F) 431 (-V) 318 (-IV) 
25 FVIY 5.58 C39H46N6O7 711 530 (-Y) 417 (-I) 318 (-VI) 
26 IYFV 4.62 C39H46N6O7 711 594 (-V) 447 (-F) 284 (-YF) 
27 FIVY 6.14 C39H46N6O7 711 530 (-Y) 431 (-V) 318 (-IV) 
28 VYFI 5.52 C39H46N6O7 711 580 (-I) 433 (-F) 270 (-YF) 
 
Supplementary Table 7.  
Sequencing data leading to the identification of linear tetrapeptides after AQC derivatization. 


















specificity of adenylation domain corresponding linear  
peptide 
A1 A2 A3 A4 
1 Phe Phe Val Val 11-13 
2 Tyr Phe Val Val 14-16 
3 Tyr Trp Val Val 17-19 
4 Phe Trp Val Val 20-22 
5 Phe Phe Val Ile 23 
6 Phe Phe Ile Val 24 
7 Tyr Trp Val Ile not observed 
8 Tyr Trp Ile Val not observed 
9 Tyr Phe Val Ile 25-26 
10 Tyr Phe Ile Val 27-28 
proposed Phe Trp Val Ile not observed 
proposed Phe Trp Ile Val not observed 
proposed Phe Phe Ile Ile not observed 
proposed Phe Trp Ile Ile not observed 
proposed Tyr Phe Ile Ile not observed 
proposed Tyr Trp Ile Ile not observed 
specificity Phe/Tyr Phe/Trp Val/Ile Val/Ile 
  
Supplementary Table 8. 
Identified and proposed cyclic and linear tetrapeptides in respect to the adenylation domain 
specificity in the NRPS HcpA. 
 
 
 
 
 
